Drugs in the Pipeline
Psilocybin Study Gets Green Light From FDA for Treatment-Resistant Depression
The trial will be a Phase 2b dose-ranging study (N=216) with patients from 12-15 research centers across Europe and North America.
Your search for smoking cessation returned 23 results
News
Varenicline Efficacy Evaluated in Nicotine Dependent Adolescents
Adverse events observed among adolescent smokers in the study were comparable to those seen in adult studies.
News
Death Risk Assessed With Contemporary Tobacco Product Use
For current non-daily cigarette smokers, there were statistically significant associations with death from lung cancer, oral cancer, circulatory death, cardiovascular death, cerebrovascular death (stroke), and chronic obstructive pulmonary disease.
News
Do the Benefits of Smoking Cessation Tx Decrease Over Time?
Benefits of smoking cessation medications decline over the first year.
News
Smoking Cessation Drug Linked to Increased Risk of Cardiovascular Events
The researchers analyzed the medical records of 56,851 new users of varenicline.
News
Gender May Impact Efficacy of Smoking Cessation Pharmacotherapy
The data showed TNP was significantly more effective vs. no medication assisted quit attempts for males (odds ratio [OR] 1.37, 95% CI: 1.02, 1.83; P=0.03) but not for females (OR 0.96, 95% CI: 0.71, 1.31; P=0.82).
News
IV Lipid Emulsion for Bupropion Poisoning: Is it Beneficial?
Researchers examined electronic records from one regional poison center for cases of intentional bupropion ingestion between January 1, 2009 to December 31, 2015. Reports that cited IV lipid emulsion administration or death as an outcome were further evaluated.
News
E-Cigarette Use May Up Bladder Cancer Risk
The researchers believe that based on their findings, e-cigarette smokers may be at increased risk for bladder cancer.
News
FDA: Boxed Warning Removed from Smoking Cessation Treatment
The FDA determined the benefits of this smoking cessation therapy outweighed the potential risks.
News
Drug Combo May Benefit Weight-Concerned Smokers Who Want to Quit
In a first-ever prospective study evaluating lorcaserin in reducing post-cessation weight gain in overweight and obese smokers, researchers found that lorcaserin combined with varenicline minimized weight gain and increases in waist circumference.
